X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - FINANCIALPOST.COM - A La Une - 17/Jan 22:01

XORTX Announces Change of Auditor

CALGARY, Alberta, Jan. 17, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease and gout, announces the Company has changed its auditor from Smythe LLP, Chartered Professional Accountants (“Former […]

Articles similaires

Sorry! Image not available at this time

Saol Therapeutics Announces FDA Acceptance of New Drug Application for SL1009 for Treatment of Pyruvate Dehydrogenase Complex Deficiency

drugs.com - 28/Jan 01:01

ROSWELL, Ga, DUBLIN and HAMILTON, Bermuda, January 28, 2025 – Saol Therapeutics, a privately held, clinical-stage pharmaceutical company,...

Sorry! Image not available at this time

CARsgen's allogeneic CD38 CAR─T therapy administers first dose in an investigator─initiated trial

pharmabiz.com - 21/Jan 13:03

CARsgen Therapeutics Holdings Limited, a company focused on innovative CAR T─cell therapies for the treatment of hematologic malignancies and solid...

Sorry! Image not available at this time

Tudor Gold Announces Appointment of Mr. Joe Ovsenek to the Board of Directors

ilrtoday.ca - 22/Jan 15:30

Press Release Vancouver, British Columbia, Canada – January 22, 2025 – Tudor Gold Corp.(TSXV: TUD) (Frankfurt: H56) (the “Company” or...

Sorry! Image not available at this time

Cielo Announces Shares for Debt Transactions

financialpost.com - 21/Jan 02:02

CALGARY, Alberta, Jan. 20, 2025 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV:CMC; OTC PINK:CWSFF) (“Cielo” or the “Company”)...

Sorry! Image not available at this time

Enveric Biosciences Announces Pricing of $5 Million Public Offering

financialpost.com - 31/Jan 01:16

CAMBRIDGE, Mass. — Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the...

Sorry! Image not available at this time

NU E Power Announces Beginning of Commercial Production at Lethbridge One Solar Project

ilrtoday.ca - 30/Jan 18:37

Press Release January 30, 2025 Calgary, Alberta–(January 30, 2025) – Nu E Power Corp. (the “Company”) (CSE: NUE) (OTC Pink: NUEPF) is pleased...

Sorry! Image not available at this time

Barrington James: Process Development Engineer

pharmiweb.com - 20/Jan 00:00

Competitive: Barrington James: The Company My client is an innovative and inclusive pharmaceutical company, we are dedicated to developing...

Sorry! Image not available at this time

Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

drugs.com - 21/Jan 18:01

WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on...

Sorry! Image not available at this time

Dyne Therapeutics Receives FDA Fast Track Designation for DYNE-101 for the Treatment of Myotonic Dystrophy Type 1

drugs.com - 21/Jan 18:01

WALTHAM, Mass., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on...

Sorry! Image not available at this time

Enveric Biosciences receives notice of allowance from USPTO for its drug candidate EB─003 to treat mental health disorders

pharmabiz.com - 08:22

Enveric Biosciences, a Naples─headquartered biotechnology company dedicated to the development of novel neuroplastogenic small─molecule...

Les derniers communiqués